Thomas Stauch/LinkedIn
Jun 13, 2026, 18:21
Thomas Stauch: Discussing the Future of ITP Research and Patient Care
Thomas Stauch, Owner of Hematology and Oncology Practice, Jena, shared a post on LinkedIn:
“One of the best things about EHA is that the conversations often continue beyond the conference itself.
After David Kuter’s excellent presentation on ITP, I had the pleasure of discussing the future of ITP research and patient care with him on the train ride home.
Thank you for the inspiring exchange and valuable insights.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters
-
Oct 28, 2026, 13:13Michael Cahillane: Three-Buffy-Coat Platelets – Strengthening Blood Supply Resilience
-
Oct 28, 2026, 13:05N. Mariana S. Vasquez: Antiplatelets vs Anticoagulants – Key Clinical Differences
-
Oct 28, 2026, 12:45Panithaya Chareonthaitawee: A Podcast Walk Through Anticoagulation
-
Oct 28, 2026, 11:55Natalia C. Badillo: Anticoagulation in AF – A Decision Beyond the Score
-
Oct 28, 2026, 08:40Simon Fletcher: The Hidden Burden of Non-Severe Haemophilia
-
Oct 28, 2026, 08:08Paul Agwu: A Low Platelet Count Is Not a Diagnosis – It Is a Clue
-
Oct 28, 2026, 07:54Ifeanyichukwu Ifechidere: When Normal Results Don’t Explain the Bleeding
-
Oct 28, 2026, 06:06Thirunavukkarasu Angappan: Anti-TFPI Antibodies and an Antithrombin-Lowering Drug